Turkish Journal of Medical Sciences
Volume 52

Number 6

Article 12

1-1-2022

Assessment of s-nitrosothiol and thiol/disulfide levels in acute
coronary syndrome patients
MEHMET MURAT YİĞİTBAŞI
ABDULLAH NABİ ASLAN
HARUN KUNDİ
MÜCAHİT FURKAN ERKILIÇ
ÖZCAN EREL

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
YİĞİTBAŞI, MEHMET MURAT; ASLAN, ABDULLAH NABİ; KUNDİ, HARUN; ERKILIÇ, MÜCAHİT FURKAN;
EREL, ÖZCAN; and KASAPKARA, HACI AHMET (2022) "Assessment of s-nitrosothiol and thiol/disulfide
levels in acute coronary syndrome patients," Turkish Journal of Medical Sciences: Vol. 52: No. 6, Article
12. https://doi.org/10.55730/1300-0144.5529
Available at: https://journals.tubitak.gov.tr/medical/vol52/iss6/12

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Assessment of s-nitrosothiol and thiol/disulfide levels in acute coronary
syndrome patients
Authors
MEHMET MURAT YİĞİTBAŞI, ABDULLAH NABİ ASLAN, HARUN KUNDİ, MÜCAHİT FURKAN ERKILIÇ,
ÖZCAN EREL, and HACI AHMET KASAPKARA

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol52/iss6/12

Turkish Journal of Medical Sciences

Turk J Med Sci
(2022) 52: 1829-1838
© TÜBİTAK
doi:10.55730/1300-0144.5529

http://journals.tubitak.gov.tr/medical/

Research Article

Assessment of s-nitrosothiol and thiol/disulfide levels in acute coronary syndrome
patients
1

2

2

3

Mehmet Murat YİĞİTBAŞI , Abdullah Nabi ASLAN , Harun KUNDİ , Mücahit Furkan ERKILIÇ ,
4
1,
Özcan EREL , Hacı Ahmet KASAPKARA *
1
Department of Cardiology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey
2
Department of Cardiology, Cardiovascular Hospital, Ankara City Hospital, Ankara, Turkey
3
Department of Biochemistry, General Hospital, Ankara City Hospital, Ankara, Turkey
4
Department of Biochemistry, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey
Received: 25.08.2022

Accepted/Published Online: 01.11.2022

Final Version: 21.12.2022

Background/aim: The level of nitric oxide (NO) is important to protect the heart from ischemic damage in acute coronary syndrome
(ACS) patients. S-nitrosothiol (SNO) is a molecule that represents the main form of NO storage in the vascular structure. In addition,
dynamic thiol/disulfide homeostasis (TDH) is known to play an important role in maintaining the oxidant-antioxidant balance. In this
study, our aim is to evaluate the oxidative/nitrosative stress status according to SNO level and TDH in patients with ACS.
Materials and methods: The study included 124 patients who were admitted to the emergency service and 124 consecutive individuals
who applied to the cardiology outpatient clinic with cardiac complaints and underwent coronary angiography (CAG). Blood was drawn
from all participants included in the study to determine SNO, nitrite, total thiol, native thiol, and disulfide levels after 12 h of fasting.
Results: Serum SNO levels were found to be significantly lower in ACS patients compared to the control group (0.3 ± 0.08 vs. 0.4 ± 0.10
μmol/L, successively, p < 0.001). In addition, while the total thiol, native thiol, and native thiol/total thiol levels were lower in the patient
group compared to the control group, nitrite, disulfide/native thiol and disulfide/total thiol levels were higher. As a result of multivariate
logistic regression analysis, it was determined that age, gender, smoking, low-density lipoprotein cholesterol, glycosylated haemoglobin,
and SNO levels were independent predictors in predicting ACS patients.
Conclusion: S-nitrosothiol and thiol levels were found to be significantly lower in ACS patients. In addition, SNO molecule was
independently associated with the presence of ACS diagnosis.
Key words: Acute coronary syndrome, ST segment elevation myocardial infarction, non-ST-elevation myocardial infarction,
S-nitrosothiol, thiol, disulfide

1. Introduction
Acute coronary syndrome (ACS) refers to a group of
clinical entities that include ST-elevation myocardial
infarction (STEMI), non-ST-elevation myocardial
infarction (NSTEMI), and unstable angina. In 90% of ACS
cases, the main underlying cause is atherosclerosis which
is associated with plaque formation consisted of fatty
deposition in arterial walls.
Oxidative stress (OS) has been reported as one of the
underlying mechanisms of CAD [1,2]. Thiols are important
antioxidant agents in humans. Thiols, containing the
sulfur analog of alcohol are found in plasma in free or
oxidized form. In conditions of high OS, thiol levels drop
to neutralize ROS with the sulfhydryl groups of thiols
playing a critical role in ensuring this [3]. Recently, it has

been reported that the thiol/disulfide ratio is a new marker
of OS and may vary in ACS [4,5].
Nitric oxide (NO) is a product of endothelium and
plays an important role in regulating the vascular tone of
blood vessels, especially in coronary circulation. Decreased
NO activity is one of the most important signs of ED [6].
The activity of NO as a cell signaling molecule via cyclic
guanosine monophosphate (cGMP) is well established.
Recent studies suggest that NO may modify proteins
posttranslationally, via a nitrosative pathway known as
S-nitrosylation [7]. S-nitrosothiols are simple organic
thioesters of nitrites or functional groups containing a
nitroso group covalently bonded to the sulfur atom of a
thiol. NO lifetime is <2 msin blood [8] and <2 s in tissues
[9]. This short lifetime is believed to be a limitation for the
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biological activity of NO. However, when NO complexes
with thiol groups form SNO, this formation prolongs
NO’s life by protecting NO from being inactivated by
metalloproteins and free radicals.
In this study, we aimed to evaluate the oxidative and
nitrosative stress status in ACS patients with SNO level
and TDH.
2. Materials and methods
2.1. Patients and study design
This study with a cross-sectional design was carried out
between September 2021 and December 2021. A total of
248 patients, 124 patients aged 18–80 years, who applied
to the adult emergency department with chest pain and
were diagnosed with ACS as a result of the examinations,
and 124 patients between the ages of 18–80, who were
similar to the patient group in terms of demographic
characteristics, were included in the study.
Patients with known heart failure (HF), cardiogenic
shock, sudden cardiac arrest, who underwent
cardiopulmonary
resuscitation
before
coronary
angiography, who needed intravenous infusion of
furosemide and received inotropic agent (dopamine,
dobutamine, noradrenaline) infusion were excluded from
the study.
ACS was diagnosed according to the 2017 Acute
Myocardial Infarction in Patients Presenting with ST
Segment Elevation European Society of Cardiology (ESC)
guidelines [10] and the 2020 Acute Coronary Syndromes
in Patients Presenting without Persistent ST Segment
Elevation [11] ESC guidelines. Control group consisted of
patients with the diagnosis of chronic coronary syndrome
(CCS) who were examined at our cardiology outpatient
clinic due to the cardiac complaints (such as chest pain,
exertional dyspnea, palpitations, syncope) and underwent
selective right and left coronary angiography (CAG)
which revealed normal coronary arteries or noncritical
CAD. The CCS diagnosis and decision of CAG was made
according to the 2019 ESC CCSs guideline [12]. Detailed
transthoracic echocardiography (TTE) was performed on
all participants by an experienced cardiologist. The study
protocol was approved by the research ethics committee of
Ankara City Hospital and was performed according to the
Declaration of Helsinki.
2.2. Laboratory analysis
For the fasting blood glucose (FBG), urea, creatinine, total
cholesterol, low-density lipoprotein (LDL) cholesterol,
high-density lipoprotein (HDL) cholesterol, triglyceride,
native thiol, total thiol, disulfide, nitrite, and SNO values
to be measured from the patient and control groups, 10
mL of blood was taken into a vacuum gel tube after 12
h of fasting and was left for 15 min at room temperature
to coagulate. After the blood was coagulated at room
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temperature, it was centrifuged at 1300 g for 10 min
and the serum was separated. The separated sera were
transferred to Eppendorf tubes and stored at –80 °C until
the study day.
S-nitrosothiol measurement was performed according
to the Saville method. In this method, mercury 2 chloride
(mercury II chloride/HgCl2) was used to liberate/separate
nitrite from SNOs. Seperated nitrite was measured
using the Griess reaction. Nitrite level was measured
colorimetrically according to the traditional Griess
reaction. The Griess method is based on the diazotization
of nitrite with a primary aromatic amine (sulfanilamide)
in acidic medium and the formation of a purple
nitrogen product with N-(1-naphthyl) ethylenediamine
hydrochloride (NED) [13]. In addition, native thiol, total
thiol, disulfide, nitrite and SNO levels of all subjects in the
patient and control groups were measured 12 h after CAG.
Serum native and total thiol concentrations were measured
by a new fully automated colorimetric method developed
by Erel et al. [14]. Modified Elman reagents were used
for thiol measurement. To measure the total thiol level, a
reducing agent, NaHB4, was added to the serum, thereby
reducing the dynamic disulfide bonds to functional
thiol groups. Formaldehyde was then added and unused
NaHB4 was consumed. All thiol groups were measured
after reacting with DTNB (5.50-dithiobis-(2-nitrobenzoic
acid). Disulfide bonds in the sample were calculated by
the equation: (total thiol – native thiol)/2. Serum collected
from brachial vein blood was used to measure cardiac
high-sensitivity Troponin I (hs-TpI) concentration using
the ADVIA Centaur TnI Ultra test (Siemens Healthieners).
The laboratory reference range was <45 ng/L.
2.3. Echocardiographic evaluation
Transthoracic echocardiography (IE33 echocardiography
system, Philips Medical Systems, Eindhoven, The
Netherlands) was performed on all patients by an
experienced cardiologist. Doppler echocardiography and
2-dimensional images were obtained from parasternal
short and long axis, apical 4-chamber, and subcostal
4-chamber views, according to the guidelines of the
American Society of Echocardiography [15]. Left
ventricular systolic and diastolic functions were analyzed
using standard two-dimensional (2D) echocardiography,
M-mode echocardiography, pulse wave (PW)
echocardiography, and tissue Doppler echocardiography.
Left atrial (LA) diameter, interventricular septum (IVS)
thickness, posterior wall (PoW) thickness, left ventricular
end-diastolic diameter (LVEDD), and left ventricular
end-systolic diameter (LVESD) were measured with
2D imaging-guided M-mode echocardiography. Left
ventricular ejection fraction was calculated using the
modified Simpson’s method. The diagnosis of ischemic
mitral regurgitation (MR) was made in patients with
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ischemic heart disease with normal valve structure and
classified as mild, moderate or advanced MR.
2.4. Coronary angiography procedure
Coronary angiography was performed radially (GE
Medical Systems, Innova IGS 620, France) using the
classical Judkins technique by experienced operators (>75
cases per year). Coronary angiographic recordings were
taken in left-to-right oblique projections with cranial
caudal angulation at a film rate of 30 frames/s. Nonionic
low osmolality contrast material (Biemexol-350 mg/mL)
was used for the procedures. Coronary flow rates were
determined using the TIMI frame count method. This
method involves calculating frame counts. Contrast is
acquired at 30 frames/s until it reaches the distal markers
given for each coronary artery. The severity of the
coronary stenosis was determined by measuring visually
and also with the help of a caliper. Percent stenosis was
calculated by measuring the lumen diameter at the point
of greatest constriction and in the adjacent normalappearing segment of the coronary artery. The stenosis
was measured as a percentage of the occluded lumen
diameter. A critical coronary artery stenosis was defined
as a narrowing of 50% or more in the left main coronary
artery and 70% or more of the lumen in the other main
coronary arteries. Noncritical coronary artery stenosis was
defined as stenosis affecting less than 50% of the diameter.
All statistical analyzes were performed using Stata
(version 16.0 MP; StataCorp). The distribution of continuous
variables was determined using the Kolmogorov-Smirnov
test. Normally distributed continuous data were presented
as mean ± standard deviation. Categorical data were
defined as the number and percentage of cases. Variables
with a statistically significant difference and a normal

distribution were compared. Student’s t-test was used for
two different groups with normal distribution. Pearson chisquare test was used for categorical variables. A univariate
logistic regression model was constructed for each variable
to show significant predictors of ACS patients, and then
those with p < 0.10 were tested using a multivariate
logistic regression model. The results of the multivariate
regression analysis were presented as odds ratios (OR) of
independent predictors of ACS and their 95% confidence
intervals (CI). Receiver operating characteristics (ROC)
curve analysis was used to demonstrate the discrimination
performance of the final model. Finally, a nomogram with
significant predictors was plotted as a graph. P-value <0.05
was considered significant.
3. Results
Of the 124 ACS patients included in the study, 73 (58.8%)
were STEMI and 51 (41.2%) were NSTEMI patients. Since
there was no patient with a diagnosis of unstable angina
pectoris (USAP) who applied to our emergency department
at the time of our study, USAP patients were not included.
STEMI patients were grouped according to the type of MI;
41 (56.1%) had inferior MI, 29 (39.7%) had anterior MI, 2
(0.02%) had lateral MI and 1 (0.01%) had high lateral MI.
The baseline characteristics of all individuals, patients,
and the control group participating in the study are shown
in Table 1. The patient group was older (p < 0.001). The rate
of smokers in the patient group was significantly higher (p
< 0.001). In addition, chronic kidney failure (CKD) and HF
rates) were found to be significantly higher in the patient
group compared to the control group (p < 0.05). There was
no significant difference between the two groups in terms
of the incidence of DM, HT, HL, and COPD.

Table 1. Baseline characteristic features of the study population.
Variables

All (n = 248)

Control (n = 124)

Patients (n = 124)

p

Age, years

60.2 ± 11.8

57.6 ± 8.7

62.9 ± 13.8

<0.001

Sex, male, n (%)

85 (34.2 %)

52 (41.9 %)

33 (26.6 %)

0.011

Smoking, n (%)

113 (45.6 %)

38 (30.6 %)

75 (60.5 %)

<0.001

HL, n (%)

142 (57.3 %)

60 (48.4 %)

82 (66.1 %)

0.005

HT, n (%)

158 (63.7 %)

74 (59.7 %)

84 (67.7 %)

0.190

DM, n (%)

88 (35.5 %)

40 (32.3 %)

48 (38.7 %)

0.290

CAD, n (%)

47 (19.0 %)

0 (0 %)

47 (37.9 %)

<0.001

COPD, n (%)

14 (5.6 %)

5 (4.0 %)

9 (7.3 %)

0.270

CRF, n (%)

19 (7.7 %)

1 (0.8 %)

18 (14.5 %)

<0.001

HF, n (%)

65 (26.2 %)

10 (8.1 %)

55 (44.4 %)

<0.001

CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; CRF: chronic renal failure; DM: diabetes mellitus;
HF: heart failure; HL: hyperlipidemia; HT: hypertension
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The biochemical and hematological laboratory values
of the entire study group, patient and control groups
are presented in Table 2. Accordingly, between the two
groups, no significant difference was observed between
platelet count, total cholesterol levels, and hemoglobin
values. However, white blood cell count, neutrophil
levels, FBG, urea, creatinine, HbA1c, hs-TpI and LDLcholesterol levels were significantly higher in the patient
group than in the control group (p < 0.05). Lymphocytes,
TG and HDL-cholesterol and glomerular filtration rate
(GFR) were found to be lower in the patient group. When
SNO and TDH parameters, which are OS biomarkers,
were examined, it was observed that the SNO level was
significantly lower in the patient group (Figure 1). Also,
native thiol and total thiol levels and native/total thiol ratio
were also found to be lower in the patient group compared
to the individuals in the control group. Moreover, nitrite

levels, disulfide/native thiol and disulfide/total thiol ratios
were significantly higher in ACS patients compared to
participants in the control group.
The transthoracic echocardiography results, CAG
results, and the treatment strategies decided in patients
with ACS and individuals in the control group are detailed
in Table 3. Accordingly, as expected, the left ventricular
ejection fraction in ACS patients was found to be
significantly lower than in the control group. In parallel,
LVEDD, LVESD, PoW thickness, and LA diameter were
also measured larger in the patient group than in the
control group. The rate of ischemic MR was also higher in
patients in the ACS group than in patients in the control
group as expected.
A multivariate logistic regression model was
constructed from variables including SNO, age, male sex,
smoking, LDL-cholesterol, and HbA1c levels to identify

Table 2. Comparison of biochemical and hematological parameters of the study population, patient, and control groups.
Variables

All (n = 248)

Control (n = 124)

Patient (n = 124)

p

WBC, 103/µL

9.60 ± 4.04

7.18 ± 2.01

12.01 ± 4.12

<0.001

Neutrophil, 103/µL

7.69 ± 13.24

4.27 ± 1.47

11.10 ± 18.07

<0.001

Lymphocyte, 10 /µL

1.91 ± 1.09

2.18 ± 0.79

1.64 ± 1.27

<0.001

Platelet, 103/µL

261.1 ± 76.8

254.7 ± 61.1

267.4 ± 89.6

0.190

Hemoglobin, g/L

14.9 ± 11.4

15.1 ± 9.1

14.7 ± 13.4

0.800

HbA1c, %

6.5 ± 1.6

6.0 ± 0.9

7.0 ± 2.0

<0.001

Total C, mg/dL

191.8 ± 46.2

193.3 ± 42.3

190.3 ± 50.0

0.610

LDL-C, mg/dL

123.8 ± 40.5

116.8 ± 34.6

130.8 ± 44.7

0.006

HDL-C, mg/dL

38.6 ± 11.7

42.9 ± 12.0

34.3 ± 9.8

<0.001

Triglyceride, mg/dL

156.7 ± 86.3

177.8 ± 90.7

135.6 ± 76.5

<0.001

FBG, mg/dL

129.7 ± 66.6

104.6 ± 40.9

154.9 ± 77.2

<0.001

Urea, mg/dL

38.0 ± 18.3

32.6 ± 9.2

43.5 ± 22.9

<0.001

Creatinine, mg/dL

0.92 ± 0.52

0.83 ± 0.19

1.01 ± 0.71

0.006

eGFR, ml/dk/1.73 m²

85.2 ± 21.7

88.0 ± 19.1

82.3 ± 23.8

0.041

Hs-Troponin I, ng/L

6250 ± 9571

6.23 ± 2.26

12,494 ± 10,265

<0.001

Native thiol, μmol/L

275.6 ± 100.1

349.2 ± 76.9

202.0 ± 57.4

<0.001

Total thiol, μmol/L

316.8 ± 103.6

391.7 ± 78.2

241.8 ± 64.1

<0.001

Disulphide, μmol/L

20.5± 5.97

21.2 ± 7.27

19.9 ± 4.21

0.078

Disulphide/Native thiol

8.3 ± 3.17

6.4 ± 3.10

10.2 ± 1.79

<0.001

Disulphide/Total thiol

7.0 ± 2.29

5.5 ± 2.18

8.4 ± 1.25

<0.001

Native/Total thiol

85.9 ± 4.57

88.8 ± 4.35

83.0 ± 2.49

<0.001

Nitrite, mg/L

3.9 ± 2.75

3.1 ± 1.89

4.7 ± 3.22

<0.001

S-Nitrosothiole, μmol/L

0.4 ± 0.09

0.4 ± 0.10

0.3 ± 0.08

<0.001

3

FBG: fasting blood glucose; eGFR: estimated glomerular filtration rate; HB: haemoglobin; HbA1c: glycosylated haemoglobin; HDL-C:
high density lipoprotein cholesterol; Hs: high sensitivity; LDL-C: low density lipoprotein cholesterol; Total-C: total cholesterol; WBC:
white blood cell
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Figure 1. Boxplots showing S-nitrosothiol levels between patient and control groups.

Table 3. Comparison of the echocardiography and treatment results of the study population.
Variables

All (n = 248)

Control (n = 124)

Patient (n = 124)

p

LVEDD, mm

45.9 ± 8.0

44.1 ± 9.3

47.7 ± 6.0

<0.001

LVESD, mm

30.4 ± 7.0

27.6 ± 6.1

33.2 ± 6.7

<0.001

IVS, mm

1.1 ± 0.7

1.0 ± 0.1

1.2 ± 0.9

0.110

PoW, mm

1.04 ± 0.12

1.03 ± 0.11

1.06 ± 0.13

0.029

LA, mm

37.5 ± 6.6

36.0 ± 5.5

39.0 ± 7.2

<0.001

LVEF, %

52.2 ± 10.5

58.5 ± 5.4

45.8 ± 10.6

<0.001

Ischemic MR, n (%)

25 (10.1%)

0 (0.0%)

25 (20.2%)

<0.001

Medical therapy

128 (51.6%)

124 (100%)

4 (3.2%)

<0.001

PCI

113 (45.6%)

0 (0)

113 (91.2%)

<0.001

CABG

7 (2.8%)

0 (0)

7 (5.6%)

<0.001

Treatment strategy

CABG: coronary artery bypass grefting; IVS: interventricular septum; LA: left atrium; LVEDD: left ventricular end diastolic
diameter; LVEF: left ventricular ejection fraction; LVESD: left ventricular end systolic diameter; MR: mitral regurgitation; PCI:
percutaneous corponary intervention

independent predictors of ACS diagnosis (Table 4). In
multivariate logistic regression analyzes, age, male sex,
smoking, HbA1c, and LDL-cholesterol were determined as
independent predictors of ACS diagnosis. Unlike previous
studies, SNO was found to be an independent predictor
of ACS diagnosis in this study. A nomogram was created
from these 6 independent variables that could be used to
predict the diagnosis of ACS (Figure 2). The importance

of each variable in this nomogram is ranked according
to the standard deviation across the nomogram scales.
Accordingly, the value of each variable is marked according
to the order in the scale and the score below is calculated.
As a result, the higher the total score is calculated, the
higher the probability that the person has ACS.
When the variables in the nomogram are examined
one by one, it is seen that the strongest independent

1833

YİĞİTBAŞI et al. / Turk J Med Sci
Table 4. Assessment of independent predictors for the diagnosis of acute coronary syndromes with multivariable
logistic regresssion analysis.
Variables

OR

95% CI

p

S-Nitrosothiol, μmol/L

0.001

(0.001–0.046)

0.002

Age, years

1.081

(1.045–1.119)

<0.001

Male sex

3.037

(1.335–6.909)

0.008

Smoking

5.310

(2.432–11.596)

<0.001

LDL-Cholesterol, mg/dL

1.012

(1.004–1.021)

<0.001

HbA1c, %

2.192

(1.551–3.097)

<0.001

HbA1c: glycosylated haemoglobin; LDL: low-density lipoprotein; CI: confidence interval; OR: odds ratio

Figure 2. Nomogram including 6 independent variables including age, sex, smoking status, S-nitrosothiol, glycosylated haemoglobin
(HbA1c and low-density lipoprotein-cholesterol (LDL) levels was created to predict the diagnosis of acute coronary syndrome (ACS).

variables that will make the most changes in the total
score are SNO and HbA1c levels. It is a well-known fact
for many years that diabetes is accepted as the equivalent
of CAD. Therefore, the fact that SNO level is one of the
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strongest independent predictors together with HbA1c is
a very valuable data for our study.
The linear diagram showing the relationship between
the level of SNO and the probability of having ACS (Figure

YİĞİTBAŞI et al. / Turk J Med Sci
3). The red dots in the figure represent the patient group,
and it is clearly seen that the probability of having ACS
decreases linearly as the SNO level increases.
The ROC curve showing the performance of the final
model in predicting ACS is shown in Figure 4. Accordingly,
the accuracy of all these variables in predicting ACS was
determined as 85% (area under the curve 0.855; 95% CI

0.839–0.953; p < 0.001). According to this model, when
the probability of having ACS is evaluated according to the
score of each variable in the nomogram, the percentage of
the margin of error that will occur can also be revealed. For
example, if we assume that the rate of SNO in predicting ACS
alone is 65% relative to the nomogram, this indicates a 20%
margin of error compared to 85% accuracy in the final model.

Figure 3. Linear diagram showing the relationship between S-nitrosothiol level and the
probability of having acute coronary syndrome (ACS).

Figure 4. The ROC curve showing the performance of the final model in predicting
acute coronary syndrome (ACS).
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4. Discussion
Our study suggested that SNO levels were significantly
reduced in both STEMI and NSTEMI patients and more
importantly probability of having ACS increased linearly
as the SNO levels decreased. In addition, it was determined
that thiol levels were significantly lower and disulfide/thiol
ratio was higher in ACS patients compared to individuals
with noncritical coronary stenosis.
Oxidative stress is an imbalance in favor of increased
reactive oxygen species (ROS) production and/or a
decrease in body’s innate antioxidant defense systems
[16]. OS participates in the pathogenesis of atherosclerosis
and risk factors and increases free radical production in
the arterial wall [17]. The major antioxidant systems in
the vascular wall are superoxide dismutases, glutathione
peroxidases, catalases, paraoxonases, thioredoxins, and
NOs [18]. Nitric oxide is a gaseous signaling molecule
produced by nitric oxide synthase in the vascular
endothelium as well as in red blood cells [19]. Due to its
role in inhibition of platelet aggregation and neutrophil
adhesion, appropriate NO levels are important in
protecting the heart from ischemic damage [20]. Also, NO
is considered a potent vasodilator and can improve blood
flow during reperfusion. However, NO is deactivated
within seconds of its production. Its biological half-life
can vary between about 6–50 s [21]. This time is estimated
to be about 3–6 s in tissue and 1–2 s in blood [22]. NO is
converted to nitrite and nitrate in the blood. Most of the
nitrate produced is excreted by the kidneys, but a smaller
part of the blood is converted to nitrite by bacteria in the
oral cavity. In this way, some of the nitrite coming into the
stomach turns into nitrogen gas and disappears; nitrate
reaching the intestine from the blood and stomach is
partially reduced to ammonia via nitrite and reabsorbed
and converted to urea and excreted from the body. In this
way, it is excreted from the body [23]. In this study, the
reason why the nitrite level was found to be significantly
higher in the patient group may be due to the catabolism
of excessively increased NO. NO creates its effects through
three different chemical reactions: These effects are;
nitrosylation, nitrosation, and nitration. Both endogenous
and exogenous NO react with thiols in proteins such as
albumin to form SNOs with a longer lifetime than NO with
vasodilatory activity [24]. Although the cardioprotective
effects of NO via the dependent cGMP pathway are known,
recent studies suggest an association between increased
SNO formation and cardioprotection [10]. A study by
Lima et al. [25] in mice showed that endogenous SNOs
offer striking protection against myocardial ischemic
injury, and this effect may be due to S nitrosylation of the
transcription factor hypoxia-inducible factor-1, which is
found in the hearts of mice under normoxic conditions. In
cardiomyocytes, S-nitrosylation occurs in multiple proteins
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[26]. When nitrosothiols such as S-nitrosocysteine,
S-nitrosoglutathione or S-nitrozoalbumin come into
contact with cells, they release their NOs. The significantly
lower SNO level in ACS patients in this study may be due
to excessively secreted NOs.
Thiols are a class of endogenous molecules that are
protective against damage caused by free radicals. Under
OS, thiols can form reversible disulfide (RSRR) bonds.
As a result of this dynamic TDH; antioxidant protection,
detoxification, signal transduction, apoptosis, regulation
of enzymatic activity, regulation of transcription factors,
and regulation of cellular signaling mechanisms can be
maintained. In recent years, the role of dynamic TDH
in the pathogenesis of cardiovascular diseases has been
emphasized [27]. In this study, we found that native and
total thiol levels were significantly reduced in patients with
ACS and thus dynamic TDH shifted to the oxidized side.
The relationship between CAD and inflammation
and OS is well-known [2]. In a previous study, it was
revealed that paraoxonase and arylesterase activities,
both of which are antioxidant molecules, are decreased
in severe CAD and this decrease predicted the severity
of CAD [28]. Some other studies have also shown that
increased OS or decreased antioxidant status is associated
with atherosclerotic coronary artery disorders [29,30].
The outcome of our study was similar to these studies, as
expected. We showed that the thiol levels were significantly
increased in the ACS group with critical coronary artery
stenosis. Also, ACS patients had statistically lower thiol
levels compared to individuals in the control group with
noncritical coronary stenosis. These results reveal a
negative relationship between thiol levels and the severity
of coronary artery stenosis. Kundi et al. [4] reported an
increased disulfide/thiol ratio in AMI and suggested
that this ratio may be an indicator for detecting acute
myocardial injury. Similarly, in our study, it was shown
that the disulfide/thiol ratio increased in proportion to
the severity of CAD. Sivri et al. [31] investigated TDH in
NSTEMI ACS patients. Similar to the results of our study,
native thiol, total thiol, and native thiol/total thiol values
were lower in the patient group compared to the control
group and disulfide/native thiol and disulfide/total thiol
values were shown to be higher in the patient group.
There are some limitations of this study. Firstly, the
sample size of our study is relatively small. Secondly, since
USAP patients were not included in the study, the results
cannot be generalized to all ACS patients. Thirdly, the results
may not cover the whole population, as the study has a single
center and nonrandomized design. Last, it would be better
if we could take blood samples from patients at admission.
In order to evaluate SNO level and TDH in ACS patients
and to generalize the results to the whole population, larger
randomized studies including USAP patients are needed.

YİĞİTBAŞI et al. / Turk J Med Sci
In conclusion, this study showed that decreased SNO
and thiol levels may be a pathophysiological cause that
may play a role in the development of ACS. Therefore, our
study may inspire future studies on the development of
new strategies in the diagnosis and treatment of ACS.
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